Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MYOD1 as a prognostic indicator in rhabdomyosarcoma.

Pediatric blood & cancer - 1 Sept 2021

Ahmed Atif A, Habeebu Sultan, Farooqi Midhat S, Gamis Alan S, Gonzalez Elizabeth, Flatt Terrie, Sherman Ashley, Surrey Lea, Arnold Michael A, Conces Miriam, Koo Selene, Dioufa Nikolina, Barr Frederic G, Tsokos Maria G

Abstract excerpt

BACKGROUND/OBJECTIVES: Rhabdomyosarcoma (RMS) is characterized by the expression of the myogenic regulatory protein MYOD1. Histologic types include alveolar, embryonal (ERMS), and spindle cell sclerosing RMS (SRMS). SRMS harbors MYOD1 mutations in a subset of adult cases in association with poor prognosis. DESIGN/METHODS: To study the level of MYOD1 protein expression and its clinical significance, we have...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Prognosis
Share to Rhabdomyosarcoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Adolescent

Share to Infant

Share to MyoD Protein

Share to Rhabdomyosarcoma, Embryonal

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 33913590
DOI: 10.1002/pbc.29085
PMCID: PMC9907363

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MYOD1 as a prognostic indicator in rhabdomyosarcoma.PMID 33913590Read ↗

MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification.Semantic proximity Read ↗

Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis.Semantic proximity Read ↗

MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes.Semantic proximity Read ↗

Biological Role and Clinical Implications of MYOD1L122R Mutation in RhabdomyosarcomaSemantic proximity Read ↗

Diffuse Myogenin Expression by Immunohistochemistry is an Independent Marker of Poor Survival in Pediatric RhabdomyosarcomaSemantic proximity Read ↗

Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma.Semantic proximity Read ↗

Methylation profiling reveals novel molecular classes of rhabdomyosarcoma.Semantic proximity Read ↗

Epithelioid rhabdomyosarcoma: a clinicopathologic and molecular study.Semantic proximity Read ↗

The expanding morphological and genetic spectrum of MYOD1 ‐mutant spindle cell/sclerosing rhabdomyosarcomas: a clinicopathological and molecular comparison of mutated and non‐mutated casesSemantic proximity Read ↗

Molecular profile of head and neck rhabdomyosarcomas: A systematic review and meta-analysis.Semantic proximity Read ↗

Challenges in the Diagnosis of Pediatric Spindle Cell/Sclerosing Rhabdomyosarcoma.Semantic proximity Read ↗

Clinicopathological Analysis of a European Cohort of MYOD1 Mutant Rhabdomyosarcomas in Children and Young Adults.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.